| Product NDC: | 16571-120 |
| Proprietary Name: | Ciprofloxacin |
| Non Proprietary Name: | CIPROFLOXACIN HYDROCHLORIDE |
| Active Ingredient(s): | 3.5 mg/mL & nbsp; CIPROFLOXACIN HYDROCHLORIDE |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16571-120 |
| Labeler Name: | PACK Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077689 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080320 |
| Package NDC: | 16571-120-25 |
| Package Description: | 48 BOTTLE in 1 CASE (16571-120-25) > 2.5 mL in 1 BOTTLE |
| NDC Code | 16571-120-25 |
| Proprietary Name | Ciprofloxacin |
| Package Description | 48 BOTTLE in 1 CASE (16571-120-25) > 2.5 mL in 1 BOTTLE |
| Product NDC | 16571-120 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CIPROFLOXACIN HYDROCHLORIDE |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | TOPICAL |
| Start Marketing Date | 20080320 |
| Marketing Category Name | ANDA |
| Labeler Name | PACK Pharmaceuticals, LLC |
| Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
| Strength Number | 3.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |